Company · CIK 1766140
Unicycive Therapeutics, Inc.
| CIK | 1766140 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | UNCY (Nasdaq) |
| First annual or quarterly report | 2021-08-16 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-296545 | 2026-06-05 | 2026-06-15 | 2 | |
| 333-283210 | 2024-11-13 | 2025-11-14 | 4 | |
| 333-266890 | 2022-08-16 | 2024-11-14 | 3 | |
| 333-280703 | 2024-07-05 | 2024-07-16 | 2 | |
| 333-273221 | 2023-07-13 | 2023-08-03 | 2 | |
| 333-256367 | 2021-05-21 | 2021-07-14 | 8 |
Filings
22| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-15 | EFFECTDeclared effective | 333-296545 | 9999999995-26-001996 |
| 2026-06-05 | S-3Shelf registered | 333-296545 | 0001213900-26-065819 |
| 2025-11-14 | 424B5Shelf takedown | 333-283210 | 0001213900-25-111042 |
| 2025-06-13 | 424B5Shelf takedown | 333-283210 | 0001213900-25-054305 |
| 2024-11-20 | EFFECTDeclared effective | 333-283210 | 9999999995-24-003533 |
| 2024-11-14 | EFFECTDeclared effective | 333-266890 | 9999999995-24-003482 |
| 2024-11-13 | S-3Shelf registered | 333-283210 | 0001213900-24-097622 |
| 2024-07-16 | EFFECTDeclared effective | 333-280703 | 9999999995-24-002180 |
| 2024-07-05 | S-3Shelf registered | 333-280703 | 0001213900-24-059531 |
| 2023-08-03 | EFFECTDeclared effective | 333-273221 | 9999999995-23-002273 |
| 2023-07-13 | S-3Shelf registered | 333-273221 | 0001213900-23-056545 |
| 2022-08-24 | EFFECTDeclared effective | 333-266890 | 9999999995-22-002486 |
| 2022-08-16 | S-3Shelf registered | 333-266890 | 0001213900-22-048239 |
| 2021-07-14 | 424B4Final prospectus | 333-256367 | 0001213900-21-036849 |
| 2021-07-12 | EFFECTDeclared effective | 333-256367 | 9999999995-21-002720 |
| 2021-07-12 | S-1/AAmendment | 333-256367 | 0001213900-21-036535 |
| 2021-07-12 | S-1/AAmendment | 333-256367 | 0001213900-21-036490 |
| 2021-06-30 | S-1/AAmendment | 333-256367 | 0001213900-21-035033 |
| 2021-06-21 | S-1/AAmendment | 333-256367 | 0001213900-21-033200 |
| 2021-06-07 | S-1/AAmendment | 333-256367 | 0001213900-21-031134 |
| 2021-05-21 | S-1Registration filed | 333-256367 | 0001213900-21-028391 |
| 2020-09-15 | DRSDraft made public | 377-03542 | 0001213900-20-026554 |